baber/WOPTO huggingface dataset:
Patent AU-2019232875-A1 (AU)
Title: Cruciate replacing artificial knee
Inventor: GARINO JONATHAN P
IPC: A61F2/38
Filed: 2019-09-19
Abstract: A knee joint prosthesis is capable of moving between an extended position and a flexion 
position. The knee joint prosthesis includes a femoral component that is configured to be 
mounted to a femur, a tibial component that is configured to be mounted to a tibia, a post 
fixedly connected to one of the femoral component and the tibial component, and a cam 
recess defined on the other of the femoral component and the tibial component that is 
configured to be engaged by the post in either the extended position or the flexion position 
of the knee joint prosthesis. The knee joint prosthesis may also include an artificial 
ligament that extends between the femoral component and the tibial component. The post 
and the ligament mimic one of the ACL and PCL.
7/11 100 
102 
11 108 110b 
110a 
A F p 
T 
112b 104 
13112a2 
FIG. 7A 
100 
102 110a 110b 
A F p 
T 
113 
112b 104 
112a 
FIG. 7B
Patent AU-2019257651-A1 (AU)
Title: Pteridinone compounds and uses thereof
Inventor: LAUFFER DAVID J
IPC: C07D471/04
Filed: 2019-04-23
Abstract: The present invention provides compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods of use thereof for reating cellular proliferate disorders (e.g. cancer).
Patent AU-2019266116-A1 (AU)
Title: Spectrometers and instruments including them
Inventor: FARSAD MAHSA
IPC: G01J3/18
Filed: 2019-05-01
Abstract: Certain configurations are described herein of an optical spectrometer comprising an echelle grating and a cross disperser and instruments including such an optical spectrometer. The optical spectrometer is configured to spatially separate provided wavelengths of light to permit detection or imaging of each provided wavelength of light. Improved sensitivities and detection limits may be achieved using the optical spectrometers described herein.
Patent AU-2019280990-A1 (AU)
Title: RNA-targeting fusion protein compositions and methods for use
Inventor: NELLES DAVID A
IPC: C12N15/113
Filed: 2019-06-07
Abstract: Disclosed are compositions comprising: (a) a sequence comprising a guide RNA (gRNA) that specifically binds a target sequence within an RNA molecule and (b) a sequence encoding a fusion protein, the sequence comprising a sequence encoding a first RNA-binding polypeptide and a sequence encoding a second RNA-binding polypeptide, wherein neither the first RNA-binding polypeptide nor the second RNA-binding polypeptide comprises a significant DNA-nuclease activity, wherein the first RNA-binding polypeptide and the second RNA-binding polypeptide are not identical, and wherein the second RNA-binding polypeptide comprises an RNA-nuclease activity. Methods of making and methods of using compositions of the disclosure are also provided. For example, compositions of the disclosure may be used in the treatment of a disease or disorder in a subject. Exemplary disease or disorders of the disclosure include genetic and epigenetic diseases or disorders.
Patent AU-2019301299-A1 (AU)
Title: A sub-THz and THz system for physiological parameters detection and method thereof
Inventor: STEINBERG YOCHANAN
IPC: A61B5/02
Filed: 2019-02-14
Abstract: The present invention provides a method and a portable non-invasive sub-THz and THz (THz) radar system for remotely detecting physiological parameters of a subject, comprising: one or more transmission means for transmitting THz signals to a subject predefined tissue; one or more reception means for receiving a THz signal of the subject, the THz signals being a reflection of the THz signal from subject tissue thereby, receiving at least one physiological parameter change; and microprocessor means coupled and configured to communicate with the transmitter means and/or the reception means for receiving and processing the reflected signals. The microprocessor comprising instructions of pre-treatment and folding the reflected signals; filtering and decimating selected portions of the folded signals and removing folded segments; decomposing of the decimated signal s into sub-component signals: identifying and removing sub-component signals due to random motions; locating quasi-periodic signal information from the remaining sub-component signals thereby, determining at least one physiological parameter of the subject based upon the quasi- periodic signal information components.
Patent AU-2019324525-A1 (AU)
Title: Carrier system comprising a carrier and a mobile device for tilling the soil and/or for manipulating flora and fauna, and method therefor
Inventor: HUSSMANN STEPHAN
IPC: G05D1/00
Filed: 2019-08-22
Abstract: The invention relates to a carrier system (10) comprising a carrier (12) and a mobile device (14) for tilling the soil and/or for manipulating flora and fauna, the carrier (12) having: a drive (16) for moving the carrier system (10); a control system (12b); an energy source (24), which co-operates with the drive (16) and provides the voltage required for operation; a receptacle (12a) for receiving and connecting to the mobile device (14); a communication unit (30); a first communication interface (36a) that co-operates with the communication unit (30) in order to exchange data with the mobile device (14) which has a dedicated interface (36b); and a second communication interface (32) that co-operates with the communication unit (30) and that at least receives control data and forwards said data to the control system (12b) for the pre-defined movement of the carrier system (10).
Patent AU-2019345932-A1 (AU)
Title: Immiscible liquids separation apparatus and method
Inventor: SUK MAREK
IPC: B01D17/02
Filed: 2019-09-20
Abstract: An immiscible liquids separation apparatus (50) comprising: a vessel comprising a first separation chamber (66) and second separation chamber (72) being in first fluid communication with the first separation chamber (66), the first separation chamber (66) being situated above the second separation chamber (72); an inlet (52) arranged at the first separation chamber (66) to allow a liquid to flow into the vessel; a low-density liquid outlet (78) arranged on the second separation chamber (72) to allow low-density liquid separated from the liquid to be removed therefrom; and a high-density liquid outlet (60) arranged at the vessel to allow high-density liquid separated from the liquid to flow out of the vessel, and a corresponding method.
Patent AU-2019351894-A1 (AU)
Title: System and methods of operation of a smart plug
Inventor: CHOUEITER GHINWA FAKHRI
IPC: H02J3/00
Filed: 2019-10-01
Abstract: A smart plug may provide a smart-plug power monitoring signal that includes information about power consumption of devices connected to the smart plug. The smart-plug power monitoring signal may be used in conjunction with power monitoring signals from the electrical mains of the building for providing information about the operation of devices in the building. For example, the power monitoring signals may be used to (i) determine the main of the house that provides power to the smart plug, (ii) identify devices receiving power from the smart plug, (iii) improve the accuracy of identifying device state changes, and (iv) train mathematical models for identifying devices and device state changes.
Patent AU-2019357423-A1 (AU)
Title: Automatic sterilization and charging of wearable device
Inventor: LENTVORSKI ANDREW
IPC: A61L2/10
Filed: 2019-09-30
Abstract: Methods, systems, devices and apparatuses for sterilizing and charging a wearable device. The sterilizing and charging apparatus includes one or more light sources. The one or more light sources are configured to detect or sterilize the wearable device. The sterilizing and charging apparatus includes a wireless charging device. The wireless charging device is configured to charge the wearable device. The sterilization and charging apparatus includes a controller coupled to the one or more light sources and the wireless charging device. The controller is configured to determine, using the one or more light sources, that the wearable device is within an enclosure. The controller is configured to sterilize the wearable device using the one or more light sources and/or wirelessly charge the wearable device using the wireless charging device.
Patent AU-2019359378-A1 (AU)
Title: Device with disposable element
Inventor: BURNS MARTIN F
IPC: H01R24/20
Filed: 2019-10-10
Abstract: The construction of a medical device having a disposable element is disclosed. Detachable elements comprising a body having a retention feature, an electrical contactor, and sensors are also disclosed. Further disclosed are detachable elements comprising a body having a hole and a retention pocket, an electrical contactor, and a printed circuit board assembly (PCB) in contact with the innermost surface of the body that forms the retention pocket. Further disclosed are detachable elements comprising a body having an opening and a printed film comprising conductive elements, where the conductive elements comprise a sensor configured to be aligned with the opening to expose the sensor. Further disclosed are reusable components having matching retention features.
Patent AU-2019397602-A1 (AU)
Title: Acidified NP, PK, NPK fertilizer granules for fertigation
Inventor: KHALEEL MOHAMED AKASHA M
IPC: C05D9/02
Filed: 2019-12-11
Abstract: Solid acidic fertilizer granules, methods for producing the same, and methods for their use in fertigation, are disclosed. The solid acidic fertilizer granules include a plant nutrient and one or more inorganic acid distributed throughout the granules. The amount of the inorganic acid is sufficient to adjust the pH value of the fertigation solution containing the dissolved fertilizer granule to an acidic pH and prevent or reduce the precipitation of calcium in the fertigation solution.
Patent AU-2019469978-A1 (AU)
Title: Connected radio local, isolated, and hybrid implementation
Inventor: VENEZIA PAUL
IPC: H04H60/73
Filed: 2019-10-07
Abstract: A radio receiver comprises radio frequency (RF) receiver circuitry that receives a radio broadcast signal, an Internet network interface, a display, a memory, processing circuitry, and a client application including instructions for execution by the processing circuitry. The client application is configured to: determine geographic location information of the radio receiver; determine radio broadcasts that are available to the radio receiver using the geographical location information; select metadata, from metadata stored in the memory, that is associated with the radio broadcasts available to the radio receiver; and present information included in the selected metadata using the display according to the received radio broadcast signal.
Patent WO-2020215120-A1 (WO)
Inventor: KELSEY CHRISTOPHER
IPC: B03C1/03
Filed: 2020-04-22
Abstract: A planar magnetic separator for haematite including a planar chamber with magnetic assemblies rotating in unison on either side of the chamber. An axial yoke between the magnetic assemblies helps complete the magnetic circuit, thus allowing a suitably strong magnetic field to be produced which enables the extraction of weakly magnetic material such as haematite.
Patent AU-2020201028-A1 (AU)
Title: Cow rumen xylose isomerases active in yeast cells
Inventor: CHEN ZHONGQIANG
IPC: C12P7/16
Filed: 2020-02-13
Abstract: OF THE INVENTION Polypeptides were identified among translated coding sequences from a metagenomic cow rumen database, that were shown to provide xylose isomerase activity in yeast cells. The xylose isomerase activity can complete a xylose utilization pathway so that yeast can use xylose in fermentation, such as xylose in biomass hydrolysate.
Patent AU-2020201321-A1 (AU)
Title: Combination therapy including an MDM2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
Inventor: CAENEPEEL SEAN
IPC: A61K31/519
Filed: 2020-02-24
Abstract: The present invention provides combination therapy that includes an MDM2 inhibitor and one or more additional pharmaceutically active agents, particularly for the treatment of cancers. The invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers.
Patent AU-2020202224-A1 (AU)
Title: Foldable Structure for Point of Sale
Inventor: CHIU HSIN-LIANG
IPC: F16C11/04
Filed: 2020-03-30
Abstract: The present invention provides a foldable structure for a point of sale (POS). The 
foldable structure comprises: a screen, a back plate of which is provided with a screen 
mounting part; a connecting arm, two ends of which are respectively provided with a first 
mounting part and a second mounting part; a base, a side plate of which is provided with a 
base mounting part; a first rotating member, coupled between the screen mounting part of 
the screen and the first mounting part of the connecting arm; and a second rotating member, 
coupled between the base mounting part of the base and the second mounting part of the 
connecting arm. The first rotating member and the second rotating member are rotated, and 
the connecting arm is folded to expand the screen and the base into a desktop type or a 
pulled-up vertical type, or the connecting arm is folded to gather the base against the back 
plate of the screen to form a wall-mounted type.
2/11 
10 
12 
24 18 16 
20 30 
FIG. 2
Patent AU-2020202953-A1 (AU)
Title: User interfaces for peer-to-peer transfers
Inventor: VAN OS MARCEL
IPC: G06Q20/04
Filed: 2020-05-04
Abstract: The present disclosure generally relates to user interfaces for managing peer-to-peer transfers. In some examples, a device provides user interfaces for initiating and managing transfers. In some examples, a device provides user interfaces corresponding to completed transfers. In some examples, a device provides user interfaces for providing visually distinguishable message object appearances based on message designation. In some examples, a device provides user interfaces for activating accounts for accepting and sending transfers. In some examples, a device provides user interfaces for exchanging accounts for use in a transfer. In some examples, a device provides user interfaces for splitting transfers between two or more accounts. In some examples, a device provides user interfaces for generating and displaying a transfers history list. In some examples, a device provides user interfaces for voice activation of transfers. In some examples, a device provides visual or haptic feedback corresponding to a transfer operation.
Patent AU-2020203447-A1 (AU)
Title: Tyrosine kinase inhibitors
Inventor: GOLDSTEIN DAVID
IPC: C07D473/34
Filed: 2020-05-26
Abstract: The present disclosure provides compounds that are tyrosine kinase inhibitors, in particular Bruton tyrosine kinase ("BTK") inhibitors, and are therefore useful for the treatment of diseases treatable by inhibition of BTK such as cancer, autoimmune, 5 inflammatory, and thromboembolic diseases. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
Patent AU-2020203908-A1 (AU)
Title: Consensus prostate antigens nucleic acid molecule encoding the same and vaccine and uses comprising the same
Inventor: WEINER DAVID B
IPC: A61K48/00
Filed: 2020-06-12
Abstract: Provided herein are consensus amino acid sequences of prostate antigens that are capable of breaking 
tolerance in a targeted species, including PSA, PSMA, STEAP and PSCA antigens. Also provided are 
nucleic acid sequences that encode one or more consensus amino acid sequences of prostate antigens 
PSA, PSMA, STEAP and PSCA, as well as genetic constructs/vectors and vaccines expressing the 
sequences. Also provided herein are methods for generating an autoimmune response against prostate 
cancer cells by administering one or more of the vaccines, proteins, and/or nucleic acid sequences that 
are provided.
Patent AU-2020217462-A1 (AU)
Title: Devices and methods for molecular diagnostic testing
Inventor: CHU STEVE
IPC: C12P19/34
Filed: 2020-08-16
Abstract: A hand-held molecular diagnostic test device includes a housing, an amplification (or PCR) 
module, and a detection module. The amplification module is configured to receive an input 
sample, and defines a reaction volume. The amplification module includes a heater such that 
the amplification module can perform a polymerase chain reaction (PCR) on the input sample.  
The detection module is configured to receive an output from the amplification module and a 
reagent formulated to produce a signal that indicates a presence of a target amplicon within the 
input sample. The amplification module and the detection module are integrated within the 
housing.
WO 2016/109691 4/61 PCTJUS2OI5/068101 
0 
00 
co 
0 Fin 
Liin 
00 
C 
m 
Ln'. _ 
N-cl 
jauC de 
LnC
Patent AU-2020231396-A1 (AU)
Title: Caspase inhibitors and methods of use thereof
Inventor: SPADA ALFRED P
IPC: C07C255/60
Filed: 2020-03-06
Abstract: Provided herein are compounds of formula (I), compositions comprising the compounds and method of treating various diseases with the compounds and compositions.
Patent AU-2020241029-A1 (AU)
Title: Filterwell cartridge holder
Inventor: GUY DAVID
IPC: B01D27/04
Filed: 2020-03-11
Abstract: A filterwell cartridge holder mountable within a hot tub filterwell with the filterwell cartridge holder having a handhold on one end and a feed pipe connector on an opposite end that is attachable to or removable from a filterwell feed pipe with the filterwell cartridge holder engaging and supporting dispensing cartridges thereon to maintain the dispensing cartridges in a dispensing mode within the filterwell.
Patent AU-2020244605-A1 (AU)
Title: Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
Inventor: SKERLJ RENATO T
IPC: A61P25/18
Filed: 2020-10-02
Abstract: The invention provides substituted pyrrolo[1,2-a]pyrimi dines and related organic compounds, 
compositions containing such compounds, medical kits, and methods for using such 
compounds and compositions to treat medical disorders, e.g., Gaucher disease, Parkinson's 
disease, Lewy body disease, dementia, or multiple system atrophy, in a patient. Exemplary 
substituted pyrrolo[1,2-a]pyrimidines compounds described herein include substituted 2,4
dimethyl-N-phenylpyrrolo[1,2-a]pyrimidine-8-carboxamide compounds and variants thereof.
Patent AU-2020250182-A1 (AU)
Title: Protein Formulations
Inventor: PARK SUNGAE
IPC: A61K39/00
Filed: 2020-10-06
Abstract: The present disclosure provides solid protein formulations that are stable over a variety of 
temperatures for extended time periods. The present disclosure also provides methods of making and 
using these formulations.
Patent AU-2020252618-A1 (AU)
Title: Heterocyclic compound and harmful arthropod pest control composition containing same
Inventor: TSURUDA TAKESHI
IPC: A01N43/653
Filed: 2020-03-27
Abstract: The present invention provides: a compound represented by Formula (I) [wherein Q is a group or the like represented by Q1, Z represents an oxygen atom or the like, A
Patent AU-2020264328-A1 (AU)
Title: Head protection system
Inventor: PRACHT STEFFEN
IPC: A42B3/28
Filed: 2020-11-04
Abstract: The invention concerns a head protection system (300), with a protective helmet (100) and a fire 
resistant fabric (200). The protective helmet has a helmet shell (105) and a retention device (108) 
for ensuring a distance (A) between an inner side (106) of the helmet shell (105) and a head 
(102) of a wearer of the protective helmet when the protective helmet is worn, wherein because 
of the distance between the inner side of the helmet shell and the head of the wearer, an air path 
(110) results between the protective helmet and the head, and wherein the air path is partially 
formed by a plurality of openings (120) of a mounting ring (125), wherein the mounting ring is 
arranged at least in the region of the forehead of the wearer when the protective helmet is worn.  
The fire resistant fabric has a mounting strap (230), wherein the mounting strap has a plurality of 
rigid mounting elements (235), each of which is designed to engage in a respective opening of 
the mounting ring and thereby releasably mount the fire resistant fabric to the protective helmet, 
and wherein when mounted the plurality of rigid mounting elements fill the plurality of openings 
in such a way that the air path through the plurality of openings is closed.
1/5 
CDO 
CDN 
CD 0 
co o
Patent AU-2020281041-A1 (AU)
Title: Fence mesh and machine for the formation thereof
Inventor: ULLRICH MARK WILLIAM
IPC: B21F15/06
Filed: 2020-12-02
Abstract: Fence mesh including line wires, and stay wires extending laterally across and intersecting the line 
wires to form a mesh, wherein a first type of wire knot is formed by a knot wire around the line wire 
and stay wire at intersections of the stay wires with the line wires in a primary zone, and wherein a 
second type of wire knot is formed by a knot wire around the line wire and stay wire at intersections 
of the stay wires with the line wires in a secondary zone, characterised in that the first type of wire 
knot is different from the second type of wire knot; and a machine for the formation of such a mesh.
301 
303 
302 
FIGURE 3
Patent AU-2020281378-A1 (AU)
Title: Anti-TrkA antibodies and uses thereof
Inventor: CHEN CHAO
IPC: A61K39/395
Filed: 2020-05-28
Abstract: Provided are an antibody or an antigen-binding fragment thereof capable of specifically recognizing TrkA and uses thereof. The antibody contains a CDR sequence selected from at least one of the following or an amino acid sequence having at least 95% identity with it: heavy chain variable region CDR sequences: SEQ ID NO: 1～27, light chain variable region CDR sequences: SEQ IN NO: 28～54. The above antibody according to the embodiment can specifically targeted-bind to the TrkA receptor and block the binding of NGF to TrkA.
Patent AU-2020283177-A1 (AU)
Title: Efficient method for preparing ppr protein and use of the same
Inventor: YAGI YUSUKE
IPC: C12N15/11
Filed: 2020-05-29
Abstract: Provided is a high-performance PPR protein. This PPR protein has more motifs that are linked together than the conventional 7 to 14 motifs and binds to a long base sequence. The PPR motifs are represented by: (A-1) PPR motif comprising a sequence of SEQ ID NO: 9 or 401; (C-1) PPR motif comprising a sequence of SEQ ID NO: 10; (G-1) PPR motif comprising a sequence of SEQ ID NO: 11; and (U-1) PPR motif comprising a sequence of SEQ ID NO:12. These motifs are useful as PPR motifs for, in the order given, adenine, cytosine, guanine, and uracil within a target base sequence.
Patent AU-2020283744-A1 (AU)
Title: Compounds targeting proteins and pharmaceutical compositions thereof, and their therapeutic applications
Inventor: CHAN KYLE W H
IPC: A61P11/00
Filed: 2020-05-22
Abstract: The present disclosure provides compounds, for example, a compound of Formula (I), that modulate a protein function and/ or restore protein homeostasis. The disclosure provides a method of modulating a protein-mediated disease, disorder, condition, or response. Compositions, including in combination with other therapeutic agents, are provided.